OPALIN

gene
On this page

Also known as TMP10HTMP10

Summary

OPALIN (oligodendrocytic myelin paranodal and inner loop protein, HGNC:20707) is a protein-coding gene on chromosome 10q24.1, encoding Opalin (Q96PE5). Central nervous system-specific myelin protein that increase myelin genes expression during oligodendrocyte differentiation.

Predicted to be involved in regulation of oligodendrocyte differentiation. Located in Golgi apparatus.

Source: NCBI Gene 93377 — RefSeq curated summary.

At a glance

  • GWAS associations: 1
  • Clinical variants (ClinVar): 35 total
  • MANE Select transcript: NM_033207

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:20707
Approved symbolOPALIN
Nameoligodendrocytic myelin paranodal and inner loop protein
Location10q24.1
Locus typegene with protein product
StatusApproved
AliasesTMP10, HTMP10
Ensembl geneENSG00000197430
Ensembl biotypeprotein_coding
OMIM617200
Entrez93377

Gene structure

Transcript identifiers

Ensembl transcripts: 9 — 9 protein_coding

ENST00000371172, ENST00000393870, ENST00000393871, ENST00000419479, ENST00000536387, ENST00000611913, ENST00000897676, ENST00000897677, ENST00000963709

RefSeq mRNA: 10 — MANE Select: NM_033207 NM_001040102, NM_001040103, NM_001284320, NM_001284321, NM_001284322, NM_001284323, NM_001284324, NM_001284326, NM_001284327, NM_033207

CCDS: CCDS41556, CCDS44466, CCDS60602, CCDS73172, CCDS73173, CCDS7448

Canonical transcript exons

ENST00000371172 — 6 exons

ExonStartEnd
ENSE000009873149634828996348345
ENSE000014545379634322196346117
ENSE000019320349635889496359002
ENSE000036552379635525596355290
ENSE000037290879634970796349826
ENSE000037358989635137896351410

Expression profiles

Bgee: expression breadth broad, 78 present calls, max score 97.00.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 7.0912 / max 904.2777, expressed in 90 samples.

FANTOM5 promoters (8 alternative TSS)

Promoter IDTPM avgSamples expressed
1108613.701587
1108591.247478
1108620.806878
1108600.661274
1108580.573871
1108640.035425
1108630.034123
1108560.031123

Top tissues by expression

227 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
lateral globus pallidusUBERON:000247697.00gold quality
corpus callosumUBERON:000233696.92gold quality
putamenUBERON:000187496.89gold quality
amygdalaUBERON:000187695.61gold quality
caudate nucleusUBERON:000187394.81gold quality
C1 segment of cervical spinal cordUBERON:000646994.29gold quality
Ammon’s hornUBERON:000195493.51gold quality
substantia nigraUBERON:000203893.45gold quality
globus pallidusUBERON:000187593.14gold quality
Brodmann (1909) area 9UBERON:001354092.67gold quality
spinal cordUBERON:000224092.60gold quality
medial globus pallidusUBERON:000247792.53gold quality
midbrainUBERON:000189192.45gold quality
nucleus accumbensUBERON:000188292.28gold quality
hypothalamusUBERON:000189891.40gold quality
substantia nigra pars reticulataUBERON:000196690.57gold quality
right frontal lobeUBERON:000281090.43gold quality
prefrontal cortexUBERON:000045190.28gold quality
temporal lobeUBERON:000187189.93gold quality
Brodmann (1909) area 46UBERON:000648389.78gold quality
dorsolateral prefrontal cortexUBERON:000983488.83gold quality
frontal cortexUBERON:000187088.80gold quality
substantia nigra pars compactaUBERON:000196588.49gold quality
postcentral gyrusUBERON:000258187.64gold quality
anterior cingulate cortexUBERON:000983587.57gold quality
cerebral cortexUBERON:000095687.11gold quality
parietal lobeUBERON:000187286.81gold quality
dorsal plus ventral thalamusUBERON:000189786.68gold quality
subthalamic nucleusUBERON:000190686.50gold quality
neocortexUBERON:000195086.43gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 2.

ExperimentMarker?Max mean expression
E-GEOD-84465yes12.31
E-ANND-3yes4.93

Regulation

Is transcription factor: no

Upstream regulators (CollecTRI, top): CREB1, MYT1, SMO

miRNA regulators (miRDB)

78 targeting OPALIN, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-3646100.0073.565283
HSA-MIR-4682100.0068.891258
HSA-MIR-3163100.0077.238605
HSA-MIR-607799.9968.042299
HSA-MIR-10401-5P99.9965.79948
HSA-MIR-450099.9972.722367
HSA-MIR-548AT-5P99.9670.832666
HSA-MIR-146A-5P99.9668.93988
HSA-MIR-146B-5P99.9669.13977
HSA-MIR-7153-5P99.9468.891006
HSA-MIR-6835-3P99.9370.492904
HSA-MIR-6744-5P99.9366.82748
HSA-MIR-311999.9271.342390
HSA-MIR-515-5P99.9269.822343
HSA-MIR-519E-5P99.9269.622358
HSA-MIR-10527-5P99.9172.283754
HSA-MIR-130599.9171.433443
HSA-MIR-548E-5P99.8972.734486
HSA-MIR-605-3P99.8869.221833
HSA-MIR-204-5P99.7971.622439
HSA-MIR-211-5P99.7971.652440
HSA-MIR-548AG99.7769.251492
HSA-MIR-431999.7669.832586
HSA-MIR-451799.7669.191867
HSA-MIR-182599.7268.111089
HSA-MIR-3059-5P99.7069.932491
HSA-MIR-548AI99.6969.241494
HSA-MIR-548BA99.6969.141514
HSA-MIR-570-5P99.6969.241494
HSA-MIR-6887-3P99.6667.831778

Literature-anchored findings (GeneRIF, showing 2)

  • highly sialylglycosylated Opalin has a role in an intermembranous function of the myelin paranodal loops in the central nervous system (PMID:18490449)
  • TMEM10 Promotes Oligodendrocyte Differentiation and is Expressed by Oligodendrocytes in Human Remyelinating Multiple Sclerosis Plaques. (PMID:30837646)

Cross-species orthologs

2 orthologs

OrganismSymbolGene ID
mus_musculusOpalinENSMUSG00000050121
rattus_norvegicusOpalinENSRNOG00000022386

Protein

Protein identifiers

OpalinQ96PE5 (reviewed: Q96PE5)

Alternative names: Oligodendrocytic myelin paranodal and inner loop protein, Transmembrane protein 10

All UniProt accessions (3): Q96PE5, A0A0A0MS47, A0A0A0MTN4

UniProt curated annotations — full annotation on UniProt →

Function. Central nervous system-specific myelin protein that increase myelin genes expression during oligodendrocyte differentiation. Promotes oligodendrocyte terminal differentiation.

Subcellular location. Cell membrane.

Tissue specificity. Brain specific; expressed in oligodendrocytes. Expressed in oligodendrocytes in remyelinating multiple sclerosis plaques.

Isoforms (4)

UniProt IDNamesCanonical?
Q96PE5-11yes
Q96PE5-22
Q96PE5-33
Q96PE5-44

RefSeq proteins (10): NP_001035191, NP_001035192, NP_001271249, NP_001271250, NP_001271251, NP_001271252, NP_001271253, NP_001271255, NP_001271256, NP_149984* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR026609OpalinFamily

UniProt features (13 total): splice variant 3, glycosylation site 3, topological domain 2, region of interest 2, chain 1, transmembrane region 1, compositionally biased region 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q96PE5-F162.880.09

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Glycosylation sites (3): 6, 12, 14

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 49 (showing top): GOBP_NEUROGENESIS, GOBP_REGULATION_OF_OLIGODENDROCYTE_DIFFERENTIATION, GOBP_REGULATION_OF_GLIAL_CELL_DIFFERENTIATION, DBP_Q6, GOBP_GLIAL_CELL_DIFFERENTIATION, GOCC_CELL_CELL_JUNCTION, GOBP_OLIGODENDROCYTE_DIFFERENTIATION, GOCC_CELL_CELL_CONTACT_ZONE, LEIN_OLIGODENDROCYTE_MARKERS, LEIN_MIDBRAIN_MARKERS, GOCC_ANCHORING_JUNCTION, PEDRIOLI_MIR31_TARGETS_UP, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, ZNF768_TARGET_GENES, MIR3646

GO Biological Process (1): regulation of oligodendrocyte differentiation (GO:0048713)

GO Molecular Function (0):

GO Cellular Component (4): Golgi apparatus (GO:0005794), plasma membrane (GO:0005886), cell-cell contact zone (GO:0044291), membrane (GO:0016020)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
regulation of glial cell differentiation1
oligodendrocyte differentiation1
cytoplasm1
endomembrane system1
intracellular membrane-bounded organelle1
membrane1
cell periphery1
cell-cell junction1
cellular anatomical structure1

Protein interactions and networks

STRING

1526 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
OPALINTMEM70Q9BUB7952
OPALINERMNQ8TAM6690
OPALINPLLPQ9Y342674
OPALINMOBPQ13875634
OPALINPLP1P04400598
OPALINENPP6Q6UWR7520
OPALINKLK6Q92876507
OPALINSEPTIN4O43236476
OPALINMBPP02686446
OPALINOLIG2Q13516425
OPALINGPR17Q13304423
OPALINOLIG1Q8TAK6423
OPALINMAGP20916422
OPALINEGR2P11161421
OPALINGADL1Q6ZQY3421

IntAct

9 interactions, top by confidence:

ABTypeScore
OPALINBTAF1psi-mi:“MI:0914”(association)0.530
TRPV2OPALINpsi-mi:“MI:0915”(physical association)0.370
OPALINGPR89Apsi-mi:“MI:0914”(association)0.350
OPALINFAM171A2psi-mi:“MI:0914”(association)0.350
GMFBRIPK2psi-mi:“MI:0914”(association)0.350
HBBHNRNPH2psi-mi:“MI:0914”(association)0.350
IL1RNPSMG1psi-mi:“MI:0914”(association)0.350
EPHA4OPALINpsi-mi:“MI:0915”(physical association)0.000

BioGRID (210): OPALIN (Synthetic Lethality), TUBGCP4 (Affinity Capture-MS), MDN1 (Affinity Capture-MS), GHITM (Affinity Capture-MS), IPO8 (Affinity Capture-MS), LGALS3 (Affinity Capture-MS), RNF213 (Affinity Capture-MS), MON2 (Affinity Capture-MS), PDS5B (Affinity Capture-MS), TMEM55B (Affinity Capture-MS), ATP2A1 (Affinity Capture-MS), BTAF1 (Affinity Capture-MS), CD97 (Affinity Capture-MS), RTTN (Affinity Capture-MS), TUBB8 (Affinity Capture-MS)

ESM2 similar proteins: A0A0B4K753, A0A3G1DJJ7, A8P353, B0DX25, B2RWJ3, F5HAM4, F5HCK7, F5HGQ8, O39830, O59776, P06481, P06498, P06849, P09266, P09707, P0C5T6, P0C9Y9, P10407, P10471, P11313, P11625, P17523, P17524, P28979, P32845, P34890, P40688, P69338, P69339, P79943, Q0A2G4, Q32LJ5, Q4JQX4, Q5SV17, Q5T7R7, Q66125, Q66262, Q6DPQ1, Q6DPT7, Q6DPU1

Diamond homologs: Q29102, Q5E9I3, Q5R461, Q7M750, Q96PE5

SIGNOR signaling

2 interactions.

AEffectBMechanism
SMO“up-regulates quantity”OPALIN“transcriptional regulation”
OPALINup-regulatesMyelination

Disease & clinical

Clinical variants and AI predictions

ClinVar

35 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance29
Likely benign0
Benign2

Top pathogenic / likely-pathogenic (0)

SpliceAI

665 predictions. Top by Δscore:

VariantEffectΔscore
10:96345990:T:Adonor_gain0.9900
10:96346119:T:Cacceptor_gain0.9900
10:96348283:TCTTA:Tdonor_loss0.9900
10:96348284:CTTA:Cdonor_loss0.9900
10:96348285:TTA:Tdonor_loss0.9900
10:96348286:TAC:Tdonor_loss0.9900
10:96348287:A:ACdonor_gain0.9900
10:96348288:C:CCdonor_gain0.9900
10:96348288:CCT:Cdonor_gain0.9900
10:96348341:CTTTC:Cacceptor_gain0.9900
10:96348344:TCCTA:Tacceptor_loss0.9900
10:96348345:CCTAA:Cacceptor_loss0.9900
10:96348347:T:Cacceptor_loss0.9900
10:96348351:T:TCacceptor_gain0.9900
10:96348360:A:ACacceptor_gain0.9900
10:96348360:A:Cacceptor_gain0.9900
10:96349708:T:TAdonor_gain0.9900
10:96348342:TTTC:Tacceptor_gain0.9800
10:96348343:TTC:Tacceptor_gain0.9800
10:96348346:C:CCacceptor_gain0.9800
10:96348351:T:Cacceptor_gain0.9800
10:96348362:A:Cacceptor_gain0.9800
10:96349702:ATCAC:Adonor_loss0.9700
10:96349703:TCA:Tdonor_loss0.9700
10:96349704:CA:Cdonor_loss0.9700
10:96349705:AC:Adonor_loss0.9700
10:96349822:CAGTC:Cacceptor_gain0.9700
10:96348344:TC:Tacceptor_gain0.9600
10:96348345:CC:Cacceptor_gain0.9600
10:96349833:C:CTacceptor_gain0.9600

AlphaMissense

907 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
10:96345970:A:GW133R0.944
10:96345970:A:TW133R0.944
10:96345968:C:AW133C0.930
10:96345968:C:GW133C0.930
10:96345950:G:CS139R0.911
10:96345950:G:TS139R0.911
10:96345952:T:GS139R0.911
10:96349792:A:TI36K0.902
10:96349789:G:CP37R0.893
10:96349792:A:CI36R0.882
10:96349777:G:TA41D0.880
10:96349771:G:TA43D0.873
10:96345960:G:TP136H0.869
10:96345966:A:GL134P0.867
10:96345971:C:AW132C0.860
10:96345971:C:GW132C0.860
10:96349789:G:TP37Q0.860
10:96345966:A:TL134H0.857
10:96355285:A:CF3L0.853
10:96355285:A:TF3L0.853
10:96355287:A:GF3L0.853
10:96345961:G:TP136T0.848
10:96345960:G:AP136L0.845
10:96345975:A:GL131S0.836
10:96346059:A:TI103K0.830
10:96345945:T:AE141V0.817
10:96349768:A:CL44R0.816
10:96349796:C:GG35R0.813
10:96349798:G:TA34E0.810
10:96355273:G:CF7L0.806

dbSNP variants (sampled 300 via entrez): RS1000121271 (10:96353164 C>A), RS1000175447 (10:96353546 G>A), RS1000300067 (10:96359472 C>A), RS1000401931 (10:96359791 G>A), RS1000447957 (10:96347584 C>T), RS1000551738 (10:96352444 C>G), RS1000690306 (10:96360013 T>G), RS1000996441 (10:96348731 G>C), RS1001019048 (10:96346773 A>C,G), RS1001047336 (10:96349131 A>G), RS1001194293 (10:96358685 G>C), RS1001214875 (10:96347545 C>T), RS1001791745 (10:96351873 A>G), RS1001844806 (10:96357866 A>G), RS1002070164 (10:96345562 C>T)

Disease associations

OMIM: gene MIM:617200 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

1 associations (top):

StudyTraitp-value
GCST009297_2BMI at 3 years old1.000000e-06

EFO canonical traits (1, from GWAS)

EFO IDTrait name
EFO:0004340body mass index

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

6 total (human), top 6 by PubMed support.

ChemicalActions (top 5)PubMed papers
bisphenol Fincreases expression1
bisphenol Adecreases methylation1
butyraldehydeincreases expression1
Arsenic Trioxideincreases expression1
Benzo(a)pyreneincreases methylation1
Valproic Acidincreases methylation1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.